Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 37 results found. Search for [ dexamethasone india ]

Results 1 to 21 of 37
BusinessToday.In
January 27, 2021
Coronvirus treatment: Plitidepsin, according to the researchers, should be considered for clinical trials based on its in vivo study results. Plitidepsin aka Aplidin is owned by Spanish pharmaceutical company Pharma Mar


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


BusinessToday.In
New Delhi, September 4, 2020
Vaccine maker Serum Institute CEO Adar Poonawalla in Fortune's global '40 under 40' listSerum Institute of India (SII) CEO Adar Poonawalla is among the \"emerging leaders\" from across the world named by Fortune in its annual list of 40 most influential people under the age of 40. Byju Raveendran, co-founder of India's leading education technology company Byju's, Reliance Jio Board Directors Isha Ambani, and Akash Ambani are the other young guns from India to feature on the coveted list.App...


PB Jayakumar
September 3, 2020
WHO's recommendation is based on three new studies, plus four other earlier trials, all involving a drug from the family of corticosteroids


PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical


Reuters
July 4, 2020
A week ago, European Medicines Agency gave its go-ahead for remdesivir to be used in adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support


Nidhi Singal
July 3, 2020
Google's June trend search report showed some interesting insights. Post the death of actor Sushant Singh Rajput on June 14, the late actor was the top trending topic across India


Associated Press
New Delhi, June 29, 2020
The 250,000 treatment courses that the company had donated to the US and other countries will run out in about a week, and the prices will apply to the drug after that


BusinessToday.In
New Delhi, June 28, 2020
While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough


BusinessToday.In
June 28, 2020
Lockdown in Maharashtra: The Chief Minister, in his address to the public, also stated that there is no place for the word 'lockdown' but we have to take our steps carefully


E Kumar Sharma
New Delhi, June 27, 2020
\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"


Rupa Burman Roy
June 27, 2020
As per researchers led by a team from the University of Oxford, Dexamethasone has proven to reduced chances of dying from COVID-19 patients on ventilation by as much as 35% and patients on oxygen by 20%


BusinessToday.In
New Delhi, June 26, 2020
Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


BusinessToday.In
June 23, 2020
Patanjali's ayurvedic medicine for COVID-19: Baba Ramdev claimed that his ayurvedic drugs have shown 100 per cent favourable results during the clinical trial


BusinessToday.In
June 23, 2020
Ramdev Patanjali's corona medicine: Earlier this month, Balkrishna had claimed that ayurvedic medicine developed by Patanjali was able to cure at least 1,000 coronavirus patients within 5-14 days


BusinessToday.In
New Delhi, June 18, 2020
India was elected as non-permanent member of the powerful UN Security Council for a two-year term on Wednesday, winning 184 votes in the 193-member General Assembly; In light of the recent clash between India and China, the trade relations between the two Asian giants are poised for a rough ride; Under its initiatives to contain the spread of COVID-19 in the national capital, Ministry of Home Affairs has recommended to the Delhi government to cap the price of coronavirus testing at Rs 2,400. Watch this and more on News Blast.Also Read: Fitch Ratings revises India's outlook to negative from stable; retains sovereign rating 'BBB-'


BusinessToday.In
New Delhi, June 18, 2020
Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government


PAGES 1 OF 2  12